Beta The Briev beta is out. Free on iPhone via TestFlight — install it in under a minute.

Join the beta ↗
Briev
Live
Business

Elizabeth Holmes allegedly backs new biotech venture while serving prison sentence

While incarcerated, Elizabeth Holmes is reported to be advising her husband’s startup Haemanthus, which has raised about $18 million for AI-driven blood-testing devices.

Elizabeth Holmes, founder of the collapsed Theranos scandal, is alleged to be shaping a new biotech startup called Haemanthus from her federal prison camp in Bryan, Texas. The company, headed by her husband Billy Evans, has attracted about $18 million in funding, with $3.5 million from personal networks and $15 million from external sources, yet it has no publicly listed scientific advisors or peer-reviewed research. Critics liken the venture to Theranos, describing it as a repeat of the previous fraud, and note that investors such as Jim Breyer and Michael Dell have refused to back it.

Holmes, who continues to assert her innocence, says she works daily on her research and remains committed to affordable healthcare. A documentary preview featuring Holmes has recently resurfaced, further drawing public attention to her ongoing activities behind bars.

Why it matters

The story shows a convicted fraudster attempting to re-enter the biotech market, raising concerns about investor vigilance and public health.

In this story

Elizabeth HolmesHaemanthusTheranos fraudbiotech startupprisonAI blood testinginvestor rejectionhealth techdocumentary
Get the beta ↗